Author:
Barak Martin,Fedorova Veronika,Pospisilova Veronika,Raska Jan,Vochyanova Simona,Sedmik Jiri,Hribkova Hana,Klimova Hana,Vanova Tereza,Bohaciakova Dasa
Abstract
AbstractDuring the past two decades, induced pluripotent stem cells (iPSCs) have been widely used to study mechanisms of human neural development, disease modeling, and drug discovery in vitro. Especially in the field of Alzheimer’s disease (AD), where this treatment is lacking, tremendous effort has been put into the investigation of molecular mechanisms behind this disease using induced pluripotent stem cell-based models. Numerous of these studies have found either novel regulatory mechanisms that could be exploited to develop relevant drugs for AD treatment or have already tested small molecules on in vitro cultures, directly demonstrating their effect on amelioration of AD-associated pathology. This review thus summarizes currently used differentiation strategies of induced pluripotent stem cells towards neuronal and glial cell types and cerebral organoids and their utilization in modeling AD and potential drug discovery.
Graphical abstract
Funder
Grantová Agentura České Republiky
Agentura Pro Zdravotnický Výzkum České Republiky
European Regional Development Fund
Ministerstvo Školství, Mládeže a Tělovýchovy
Publisher
Springer Science and Business Media LLC
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献